Association of reduced relative dose intensity and survival in lymphoma patients receiving CHOP-21 chemotherapy

por Pettengell, R., Schwenkglenks, M., Bosly, A.
Publicado 2008

Lymphoma survivors’ experience of participation in a home-based intervention post-chemotherapy

por Hathiramani, Suchita, Pettengell, R., Moir, H., Younis, A.
Publicado 2019

Relaxation versus exercise for improved quality of life in lymphoma survivors—a randomised controlled trial

por Hathiramani, Suchita, Pettengell, R., Moir, H., Younis, A.
Publicado 2020

Patterns of mortality after prolonged follow-up of a randomised controlled trial using granulocyte colony-stimulating factor to maintain chemotherapy dose intensity in non-Hodgkin'...

por Clamp, A R, Ryder, W D J, Bhattacharya, S, Pettengell, R, Radford, J A
Publicado 2008

Long-term follow-up of patients treated with radiotherapy alone for early-stage histologically aggressive non-Hodgkin's lymphoma

por Spicer, J, Smith, P, Maclennan, K, Hoskin, P, Hancock, B, Linch, D, Pettengell, R
Publicado 2004

Recombinant human granulocyte colony-stimulating factor (filgrastim) following high-dose chemotherapy and peripheral blood progenitor cell rescue in high-grade non-Hodgkin's lympho...

por Lee, S. M., Radford, J. A., Dobson, L., Huq, T., Ryder, W. D., Pettengell, R., Morgenstern, G. R., Scarffe, J. H., Crowther, D.
Publicado 1998

A study of ovarian cancer patients treated with dose-intensive chemotherapy supported with peripheral blood progenitor cells mobilised by filgrastim and cyclophosphamide.

por Weaver, A., Wrigley, E., Watson, A., Chang, J., Collins, C. D., Jenkins, B., Gill, C., Pettengell, R., Dexter, T. M., Testa, N. G., Crowther, D.
Publicado 1996

Favourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3–5) treated with front-line R-CODOX-M/R-IVAC chemotherapy: results of a phase 2 UK NCRI trial()

por McMillan, A.K., Phillips, E.H., Kirkwood, A.A., Barrans, S., Burton, C., Rule, S., Patmore, R., Pettengell, R., Ardeshna, K.M., Lawrie, A., Montoto, S., Paneesha, S., Clifton-Hadley, L., Linch, D.C.
Publicado 2020